Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Brainstorm Cell Therapeutics Inc. (BCLI) had Weighted-Average Shares Outstanding (Diluted) of 9.27M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.31M |
|
-- |
|
-- |
|
$9.95M |
|
$-9.95M |
|
$-0.35M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-9.95M |
|
$-9.75M |
|
9.27M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
9.27M |
$-1.11 |
|
$-1.11 |
|
| Balance Sheet Financials | |
$0.31M |
|
$0.23M |
|
$0.71M |
|
$1.02M |
|
$11.01M |
|
-- |
|
-- |
|
$11.01M |
|
$-9.98M |
|
$-9.98M |
|
$-9.98M |
|
11.04M |
|
| Cash Flow Statement Financials | |
$-6.97M |
|
$0.00M |
|
$6.88M |
|
$0.37M |
|
$0.28M |
|
$-0.10M |
|
$1.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-- |
|
-0.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
103.22% |
|
103.22% |
|
-1008.51% |
|
103.22% |
|
$-0.90 |
|
$-0.75 |
|
$-0.75 |
|